Duration of obesity is not a risk factor for type 2 diabetes mellitus, arterial hypertension and hyperlipidemia

Diabetes, Obesity and Metabolism

Volumn 5, Issue 6, 2003, Pages 432-437

  Hekimsoy, Zeliha ^a,c   Oktem, I K ^b  

^a CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Izmir Ataturk Training   (Turkey)

^c NONE   (Turkey)

Author keywords

Arterial hypertension; Duration of obesity; Hyperlipidaemia; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY DISTRIBUTION; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOMES RESEARCH; RISK FACTOR;

EID: 0344034781     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2003.00298.x     Document Type: Article

References (20)

1. Pontiroli AE, Galli L. Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidemia. Acta Diabetol 1998; 35 (3): 130-136.
2. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willet UK. Obesity, fat distribution and weight gain as risk factors for clinical diabetes in man. Diabetes Care 1994; 17: 961-969.
3. Wilding J, Williams G. Diabetes and obesity. In: Kopelman PG, Stock MJ eds. Clin Obes, London: Blackwell Science, 1998; 308-349.
4. Blair D, Habicht JP, Sims EA, Sylwester D, Abraham S. Evidence for an increased risk for hypertension for centrally located body fat and the effect of race and sex on this risk. Am J Epidemiol 1984; 119: 526-540.
5. Troisi R, Weiss ST, Segal MR, Cassano PA, Vokonas PS, Landsberg L. The relationship of body fat distribution to blood pressure in normotensive men: the normative ageing study. Int J Obes 1990; 14: 515-525.
6. Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA 1978; 240: 1607-1610.
7. Wilding J, Williams G. Obesity and lipoprotein metabolism. In: Kopelman PG, Stock MJ eds. Clin Obes, Oxford: Blackwell Science, 1998: 176-204.
8. Sakurai Y, Teruya K, Shimada N et al. Association between duration of obesity and risk of non-insulin-dependent diabetes mellitus: the Sotetsu study. Am J Epidemiol 1999; 149: 256-260.
9. Mykkanen L, Laakso M, Uusitupa M, Pyorala K. Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 1990; 13: 1099-1105.
10. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998; 21 (Suppl. 1): S5-S19.
11. Sakurai Y. Duration of obesity and risk of non-insulin-dependent diabetes mellitus. Biomed Pharmacother 2000; 54: 80-84.
12. Carlsson S, Persson PG, Alvarsson M et al. Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol 1998; 148: 539-545.
13. Everhart JE, Pettitt DJ, Bennet PH, Knowler WC. Duration of obesity increases the incidence of NIDDM. Diabetes 1992; 41: 235-240.
14. Felber JP, Golay A, Jequier E et al. The metabolic consequences of long-term human obesity. Int J Obes 1988; 12: 377-389.
15. Holbrook TL, Barret-Connor E, Wingard DL. The association of lifetime weight and weight control patterns with diabetes among men and women in an adult community. Int J Obes 1989; 13: 723-729.
16. Ferrannini E, Camastra S. Relationship between impaired glucose tolerance, non- insulin-dependent diabetes mellitus and obesity. Eur J Clin Invest 1998; 28 (Suppl. 2): 3-6.
17. Reisin E, Frohlich ED, Messerli FH et al. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 1983; 98: 315-319.
18. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304: 930-933.
19. Tuck ML. Role of salt in the control of blood pressure in obesity and diabetes mellitus. Hypertension 1991; 17 (Suppl. 1): I135-I142.
20. Wilding J, Williams G. Systemic effects of obesity. In: Kopelman PG, Stock MJ eds. Clin Obes, Oxford: Blackwell Science, 1998:205-225.